Grants per year
Personal profile
Certifications and Licenses
| Pulmonary Disease | |
| Internal Medicine | |
| Critical Care Medicine |
Training Experience
| 2007 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
| 2010 | Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, University of Illinois - Chicago
… → 2004
MS, University of Illinois - Chicago
… → 2000
Research interests
- Chronic Infections
- Cystic Fibrosis
- Obstructive Airway Disease
Fingerprint Dive into the research topics where Michelle Prickett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 0 Similar Profiles
Cystic Fibrosis
Medicine & Life Sciences
Pseudomonas Infections
Medicine & Life Sciences
Pseudomonas aeruginosa
Medicine & Life Sciences
Gene therapy
Chemical Compounds
Aminoglycosides
Medicine & Life Sciences
Infectious Pregnancy Complications
Medicine & Life Sciences
Genetic Therapy
Medicine & Life Sciences
Mutation
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants 2008 2020
ACGME Back to Bedside Initiative
Accreditation Council for Graduate Medical Education
7/1/19 → 12/31/20
Project: Research project
A Pilot Study to Define Colistin Population PK and Interrogate Renal TD
Cystic Fibrosis Foundation Therapeutics, Inc.
11/1/17 → 10/31/19
Project: Research project
Colistin
Kidney
Pharmaceutical Preparations
Population
Anti-Bacterial Agents
Development of Standardized Measures of barriers to Treatment Adherence: Field Testing and Psychometric Validation
Children's Hospital Boston, Cystic Fibrosis Foundation Therapeutics, Inc.
3/1/17 → 2/28/20
Project: Research project
Psychometrics
Cystic Fibrosis
Therapeutics
Surveys and Questionnaires
Prot #PS-G202: A Phase 2a, Randomized, Double-blind, Placebo-controlled, Incomplete Block Crossover Study to Evaluate the Safety and Efficacy of VX-371 Solution for Inhalation in Subjects with Primary Ciliary Dyskinesia
INC Research, LLC, Parion Sciences, Inc.
12/1/16 → 12/1/19
Project: Research project
Subproject for Fixed-price costs for "Success with Therapies Research Consortium (STRC)" study
Children's Hospital Boston, Cystic Fibrosis Foundation Therapeutics, Inc.
11/1/16 → 10/31/19
Project: Research project
Self Care
Cystic Fibrosis
Costs and Cost Analysis
Health
Research
Research Output 2008 2018
2
Citations
(Scopus)
Polymyxin B Pharmacokinetics in Adult Cystic Fibrosis Patients
Avedissian, S. N., Miglis, C., Kubin, C. J., Rhodes, N. J., Yin, M. T., Cremers, S., Prickett, M. & Scheetz, M. H., Jul 1 2018, In : Pharmacotherapy. 38, 7, p. 730-738 9 p.Research output: Contribution to journal › Article
Polymyxin B
Cystic Fibrosis
Pharmacokinetics
Microbial Sensitivity Tests
Area Under Curve
4
Citations
(Scopus)
The relationship between sweat chloride levels and mortality in cystic fibrosis varies by individual genotype
Espel, J. C., Palac, H. L., Bharat, A., Cullina, J., Prickett, M., Sala, M. A., McColley, S. A. & Jain, M., Jan 1 2018, In : Journal of Cystic Fibrosis. 17, 1, p. 34-42 9 p.Research output: Contribution to journal › Article
Sweat
Cystic Fibrosis
Chlorides
Genotype
Mortality
13
Citations
(Scopus)
Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene
Prickett, M., Hauser, A. R., McColley, S. A., Cullina, J., Potter, E., Powers, C. & Jain, M., Jan 1 2017, In : Thorax. 72, 1, p. 40-47 8 p.Research output: Contribution to journal › Article
Aminoglycosides
Cystic Fibrosis
Pseudomonas aeruginosa
Amikacin
Mutation
Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: A single center study
Espel, J. C., Palac, H. L., Cullina, J. F., Clarke, A. P., McColley, S. A., Prickett, M. H. & Jain, M., Nov 29 2017, In : BMC Pulmonary Medicine. 17, 1, 160.Research output: Contribution to journal › Article
Cystic Fibrosis
Anti-Bacterial Agents
Lung
Therapeutics
Pseudomonas Infections
Bronchiectasis: The dawn of a new era?
Prickett, M. & Waterer, G., Jan 1 2014, In : Clinical Pulmonary Medicine. 21, 3, p. 134-137 4 p.Research output: Contribution to journal › Review article
Bronchiectasis
Macrolides
Cystic Fibrosis
Publications
Fibrosis